Pre-implant screening guided by cardiac silhouette fluoroscopy: a way to increase eligibility for the subcutaneous implantable cardioverter-defibrillator: a case report.

Autor:	Galizia Brito V; Department of Cardiology (Cardiac Arrhythmia and Electrophysiology Unit), Hospital Universitario Son Espases, Carretera de Valldemossa 79, Palma de Mallorca,Spain., Bibiloni Cladera A; Department of Cardiology (Cardiac Arrhythmia and Electrophysiology Unit), Hospital Universitario Son Espases, Carretera de Valldemossa 79, Palma de Mallorca,Spain., Exposito Pineda MDC; Department of Cardiology (Cardiac Arrhythmia and Electrophysiology Unit), Hospital Universitario Son Espases, Carretera de Valldemossa 79, Palma de Mallorca,Spain., Grande Morales C; Department of Cardiology (Cardiac Arrhythmia and Electrophysiology Unit), Hospital Universitario Son Espases, Carretera de Valldemossa 79, Palma de Mallorca,Spain.
Jazyk:	angličtina
Zdroj:	European heart journal. Case reports [Eur Heart J Case Rep] 2020 Dec 29; Vol. 5 (1), pp. ytaa495. Date of Electronic Publication: 2020 Dec 29 (Print Publication: 2021).
DOI:	10.1093/ehjcr/ytaa495
Abstrakt:	Background: Suitability for the subcutaneous implantable cardioverter-defibrillator (S-ICD) depends on a pre-implant electrocardiogram (ECG) screening to ensure appropriate sensing of electrical cardiac signals. Screening is performed positioning electrodes guided by chest surface anatomical landmarks. Case Summary: We report a case of a patient with an initially negative conventional automatic screening for S-ICD, who underwent a modified screening guided by cardiac silhouette position, as seen under fluoroscopy, resulting in eligibility for the S-ICD. Discussion: The S-ICD reduces endovascular infection risk, providing therefore a potentially safer alternative in patients with prosthetic valves. It might be reasonable to perform a pre-implant ECG screening guided by fitting the cardiac silhouette in the shock vector, as this modified screening position could increase eligibility in patients who may benefit from S-ICD therapy such as the one presented. (© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu